Internal Medicine · Birmingham, AL
NPI
1588613020
Since 2006
Specialty
Internal Medicine
Code 207R00000X
Group practices
0
Medicare group memberships
Hospitals
1
Hospital affiliations
1160 Huffman Rd, Parkway Medical Center
Birmingham, AL, 35215
Phone (205) 815-5000
Medicare paid, 2024
$50K
3,506 services
Medicare patients, 2024
145
Average age 69
Drug cost, 2024
$5.9M
50,039 prescriptions
Company payments, 2025
$8,950
From 31 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by James G Sullivan was code J1100 (injection, dexamethasone sodium phosphate, 1 mg), 630 times for 34 patients. In total James G Sullivan billed 3,506 services in 55 codes, and Medicare paid $50K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2011-07-20.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J1100 Injection, dexamethasone sodium phosphate, 1 mg | Office | 630 | 34 | $0.08 | $52.16 |
| 99214 Office E&M - Established | Office | 341 | 132 | $69.65 | $24K |
| 80305 Drug Tests | Office | 217 | 100 | $12.35 | $2,680 |
| 96372 Injection Administration | Office | 128 | 48 | $8.70 | $1,114 |
| G0444 Annual depression screening, 5 to 15 minutes | Office | 77 | 77 | $16.80 | $1,294 |
| 99213 Office E&M - Established | Office | 71 | 43 | $56.07 | $3,981 |
| G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 69 | 69 | $117.52 | $8,109 |
| J0696 Injection, ceftriaxone sodium, per 250 mg | Office | 60 | 12 | $0.29 | $17.3 |
| J1580 Injection, garamycin, gentamicin, up to 80 mg | Office | 50 | 20 | $1.13 | $56.52 |
| 81002 Clinical Chemistry | Office | 49 | 35 | $3.41 | $167 |
| 99205 Office E&M - New | Office | 14 | 14 | $123.01 | $1,722 |
| 71046 X-ray - Chest | Office | 12 | 11 | $22.07 | $265 |
By year: 2022 $61K for 2,643 services; 2023 $51K for 2,140 services; 2024 $50K for 3,506 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 80305 Drug Tests | 217 | 100 | $12.35 | $2,680 |
| 81002 Clinical Chemistry | 49 | 35 | $3.41 | $167 |
Medicare prescription drug claims, 2024
In 2024, the drug James G Sullivan prescribed most often to Medicare patients was Buprenorphine-Naloxone (Buprenorphine Hcl/Naloxone Hcl), with 2,431 prescriptions and refills. In total James G Sullivan wrote 50,039 Medicare prescriptions that cost $5.9M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Buprenorphine-Naloxone Buprenorphine Hcl/Naloxone Hcl | 2,431 | 2,444 | 252 | $546K |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 1,883 | 1,889 | 277 | $30K |
| Gabapentin Generic | 1,622 | 1,854 | 263 | $21K |
| Pantoprazole Sodium Generic | 1,434 | 3,140 | 374 | $12K |
| Alprazolam Generic | 1,292 | 1,332 | 147 | $3,697 |
| Buprenorphine Hcl Generic | 1,158 | 1,163 | 147 | $52K |
| Clonazepam Generic | 1,151 | 1,166 | 131 | $6,139 |
| Atorvastatin Calcium Generic | 1,036 | 2,661 | 279 | $10K |
| Famotidine Generic | 1,004 | 2,280 | 279 | $16K |
| Levothyroxine Sodium Generic | 888 | 2,110 | 225 | $10K |
| Albuterol Sulfate Hfa Albuterol Sulfate | 771 | 1,006 | 184 | $29K |
| Tramadol Hcl Generic | 724 | 727 | 125 | $7,459 |
| Ondansetron Hcl Generic | 716 | 737 | 125 | $6,020 |
| Quetiapine Fumarate Generic | 667 | 1,027 | 126 | $7,951 |
| Trazodone Hcl Generic | 631 | 1,260 | 148 | $5,849 |
Brand drugs: 5,938 claims; generic drugs: 43,860 claims; opioid claims: 2,850.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid James G Sullivan $8,950 ($8,950 in general payments such as food, travel and fees) from 31 companies. The largest payer was Amgen Inc. with $3,618.
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. AMGN | 18 | $3,618 |
| Indivior Inc. INDV | 10 | $3,192 |
| Novo Nordisk Inc NVO | 18 | $315 |
| AstraZeneca Pharmaceuticals LP AZN | 12 | $264 |
| Otsuka America Pharmaceutical, Inc. 4578.T | 8 | $177 |
| Braeburn Inc. | 6 | $173 |
| Pfizer Inc. PFE | 9 | $151 |
| Lilly USA, LLC LLY | 6 | $127 |
| GlaxoSmithKline, LLC. GSK | 4 | $101 |
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 5 | $101 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.